Matches in Wikidata for { <http://www.wikidata.org/entity/Q92581345> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q92581345 description "am 13. Januar 2020 veröffentilchter wissenschaftilcher Artikel" @default.
- Q92581345 description "article scientifique publié en 2020" @default.
- Q92581345 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92581345 description "scientific article published on 13 January 2020" @default.
- Q92581345 description "wetenschappelijk artikel" @default.
- Q92581345 description "наукова стаття, опублікована 13 січня 2020" @default.
- Q92581345 description "научная статья опубликована 13 января 2020 года" @default.
- Q92581345 name "Letter by Dalmau Regarding Article, "Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B)"" @default.
- Q92581345 name "Letter by Dalmau Regarding Article, "Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B)"" @default.
- Q92581345 type Item @default.
- Q92581345 label "Letter by Dalmau Regarding Article, "Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B)"" @default.
- Q92581345 label "Letter by Dalmau Regarding Article, "Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B)"" @default.
- Q92581345 prefLabel "Letter by Dalmau Regarding Article, "Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B)"" @default.
- Q92581345 prefLabel "Letter by Dalmau Regarding Article, "Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B)"" @default.
- Q92581345 P1433 Q92581345-3E35A053-D81C-4335-86FD-B38DD9CD7D97 @default.
- Q92581345 P1476 Q92581345-61E454C4-A823-4B78-8A67-F70463061CFD @default.
- Q92581345 P2093 Q92581345-6453DF73-BB72-48EC-A671-ACD9C9585AAC @default.
- Q92581345 P304 Q92581345-C725DA54-2E49-4585-A505-1B8355E4505C @default.
- Q92581345 P31 Q92581345-C8689833-4BC2-4CCD-936A-0EA31D4DEB0C @default.
- Q92581345 P356 Q92581345-FD319F5B-D7F8-4D2F-9511-355DE9E9E17C @default.
- Q92581345 P433 Q92581345-4FA9DB40-545C-49BF-AD4B-8B82A4CE73D7 @default.
- Q92581345 P478 Q92581345-F79A3C09-1920-4A8B-AF2C-585EDFC83721 @default.
- Q92581345 P577 Q92581345-E091EC1D-6EE2-4891-BAD7-FEB5462D6C5B @default.
- Q92581345 P698 Q92581345-135B1E61-56CB-4748-8342-A611EB756CDB @default.
- Q92581345 P356 STROKEAHA.119.027885 @default.
- Q92581345 P698 31928149 @default.
- Q92581345 P1433 Q7624282 @default.
- Q92581345 P1476 "Letter by Dalmau Regarding Article, "Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B)"" @default.
- Q92581345 P2093 "Josep Dalmau" @default.
- Q92581345 P304 "e28" @default.
- Q92581345 P31 Q13442814 @default.
- Q92581345 P356 "10.1161/STROKEAHA.119.027885" @default.
- Q92581345 P433 "2" @default.
- Q92581345 P478 "51" @default.
- Q92581345 P577 "2020-01-13T00:00:00Z" @default.
- Q92581345 P698 "31928149" @default.